PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

BMC study: New Hepatitis C treatments cost-effective, but only for selected patients

2015-03-30
(Press-News.org) BOSTON -A study led by Boston Medical Center (BMC) researchers demonstrates that while new therapies to treat Hepatitis C Virus (HCV) are highly effective, they are cost-effective and provide the greatest value in specific groups of HCV-infected patients. The findings of the study, led by Benjamin P. Linas, MD, MPH, from BMC's section of infectious diseases and the Boston University School of Medicine (BUSM), are published in the Annals of Internal Medicine.

The study focused on the combination of sofosbuvir and ribavirin for treatment of HCV genotypes 2 and 3, which account for approximately one quarter of all HCV cases in the United States. These medications were the first all oral combination therapy approved for the treatment of HCV. While this medication regimen is effective in curing more than 90 percent of patients, the wholesale cost of sofosbuvir is approximately $85,000 per treatment course, which has strained insurance budgets and led to treatment restrictions.

Using a simulation model, Linas and colleagues projected outcomes, costs, and cost-effectiveness of sofosbuvir-based treatments for HCV genotype 2 or 3 infection in the US. They found that at these costs, sofosbuvir-based HCV therapy provides excellent economic value in genotype 2 or 3 infected patients who already have advanced liver disease. It also is cost-effective for patients who have already previously failed treatment with other drugs.

For patients without liver disease and who have never before been treated for HCV, however, these therapies cost well over $100,000 for each quality-adjusted life year gained, suggesting that for this healthier group of patients, the medication cost is too high to be considered cost-effective.

"These new oral treatments provide better clinical results with fewer side effects for all patients, but at the current price, are only good value for those who need treatment the most - patients with advanced liver disease or those who failed prior therapy," Linas said. "With lower costs, it would be reasonable to provide these better regimens to all patients."

INFORMATION:

This study was funded in part by the National Institute on Drug Abuse and the National Institute of Allergy and Infectious Disease under notice of grant award numbers R01DA031059, R01DA027379, and R37AI042006 and was carried out in collaboration with researchers at the University of Chicago, Weill Cornell Medical College, the Harvard School of Public Health, and Massachusetts General Hospital.

About Boston Medical Center

Boston Medical Center is a private, not-for-profit, 482-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. It is the largest and busiest provider of trauma and emergency services in New England. Committed to providing high-quality health care to all, the hospital offers a full spectrum of pediatric and adult care services including primary and family medicine and advanced specialty care with an emphasis on community-based care. Boston Medical Center offers specialized care for complex health problems and is a leading research institution, receiving more than $118 million in sponsored research funding in fiscal year 2014. It is the 11th largest recipient of funding in the U.S. from the National Institutes of Health. In 1997, BMC founded Boston Medical Center Health Plan, Inc., now one of the top ranked Medicaid MCOs in the country, as a non-profit managed care organization. It does business in Massachusetts as BMC HealthNet Plan and as Well Sense Health Plan in New Hampshire, serving more than 315,000 people, collectively. Boston Medical Center and Boston University School of Medicine are partners in the Boston HealthNet - 14 community health centers focused on providing exceptional health care to residents of Boston. For more information, please visit http://www.bmc.org.



ELSE PRESS RELEASES FROM THIS DATE:

Study shows short & long-term cost-savings associated with minimally invasive surgery

2015-03-30
CLEVELAND - Adding to the clinical benefits and improved patient outcomes associated with minimally invasive surgery, Medtronic highlighted a study published in the March 25 online edition of JAMA Surgery. The new study demonstrated that patients who underwent laparoscopic colectomy procedures required fewer days of health care utilization and the health care system spent less on their acute and follow-up care than those who underwent traditional open surgery. "We found that the use of minimally invasive laparoscopic approaches in a select group of patients undergoing ...

New data show that women of childbearing age need more vegetables, white potatoes

2015-03-30
(Boston, MA) March 30, 2015 - A new study presented today at Experimental Biology 2015 confirms that vegetable consumption is very low among women of childbearing age (WCBA), and that the nutrient-rich white potato is an important vegetable to this population's diet, particularly among subgroups with the lowest intake. The results are consistent with the Institute of Medicine findings that mean total vegetable consumption of women ages 19 to 50 years is extremely low--with intakes at just 50% of the 2.5 cup equivalents per day recommended for most WCBA by the 2010 Dietary ...

Mist-collecting plants may bioinspire technology to help alleviate global water shortages

Mist-collecting plants may bioinspire technology to help alleviate global water shortages
2015-03-30
WASHINGTON D.C., March 30, 2015 - Plants living in arid, mountainous and humid regions of the planet often rely on their leaves to obtain the moisture they need for survival by pulling mist out of the air. But how exactly they manage this feat has been a bit of a mystery--until now. By studying the morphology and physiology of plants with tiny conical "hairs" or microfibers on the surface of their leaves, such as tomatoes, balsam pears and the flowers Berkheya purpea and Lychnis sieboldii, a team of researchers in Japan uncovered water collection-and-release secrets that ...

To statin or not to statin?

2015-03-30
Cholesterol-lowering statins have transformed the treatment of heart disease. But while the decision to use the drugs in patients with a history of heart attacks and strokes is mostly clear-cut, that choice can be a far trickier proposition for the tens of millions of Americans with high cholesterol but no overt disease. Now a report from preventive cardiologists at Johns Hopkins and elsewhere offers a set of useful tips for physicians to help their patients make the right call. The report, published March 30 in the Journal of the American College of Cardiology, combines ...

York U study: Functional decline in women at Alzheimer's risk relates to deteriorating brain wiring

2015-03-30
TORONTO, March 30, 2015 - In their latest brain imaging study on women at risk for Alzheimer's disease, York University researchers have found deterioration in the pathways that serve to communicate signals between different brain regions needed for performing everyday activities such as driving a car or using a computer. "We observed a relationship between the levels of deterioration in the brain wiring and their performance on our task that required simultaneous thinking and moving; what we see here is a result of communication failure," explains Professor Lauren Sergio ...

Oral drug normalizes blood potassium in 98 percent of kidney patients

2015-03-30
SAN ANTONIO, Texas, U.S.A. (March 30, 2015) -- Patients with chronic kidney disease may be treated with a class of medications called Renin Angiotensin Aldosterone System inhibitors (RAASI's). Although these drugs protect the heart and kidney, a significant percentage of patients develop a dangerous side effect -- high potassium levels in the blood (hyperkalemia). Elevated potassium puts patients at risk of death from cardiac arrhythmias. Lacking a drug to treat the problem, doctors either stop these beneficial drugs or may use kidney dialysis to quickly lower the potassium. At ...

Teens with breast lumps may be able to avoid invasive biopsy

2015-03-30
If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy. However, breast cancer is rare in adolescents, and the vast majority of teenage breast lumps turn out to be benign masses that are related to hormones and often go away over time. A recent Loyola University Health System study published in the Journal of Ultrasound in Medicine suggests that a breast ultrasound examination might eliminate the need for biopsy in many cases. Loyola radiologists studied 37 teen girls with a total of 45 breast lumps to determine whether ...

How DNA alarm-system works

How DNA alarm-system works
2015-03-30
The DNA molecule is chemically unstable giving rise to DNA lesions of different nature. That is why DNA damage detection, signaling and repair, collectively known as the DNA damage response, are needed. The DNA damage response is immensely important, for example, for ensuring the highest possible quality of the DNA before replication - duplication of the DNA prior to cell division. If the damaged DNA is replicated, the risk of cancer and other diseases increases significantly due to mutations. All in all this may lead to the death of a cell itself. DNA repair consists ...

Fasting and less-toxic cancer drug may work as well as chemotherapy

2015-03-30
Fasting in combination with chemotherapy has already been shown to kill cancer cells, but a pair of new studies in mice suggests that a less-toxic class of drugs combined with fasting may kill breast, colorectal and lung cancer cells equally well. If shown to work in humans, this combination could replace chemotherapy and make fasting a potent component of a long-term strategy to treat cancer, according to senior author Valter Longo of USC. Human clinical trials in the United States and Europe are already studying the effectiveness and safety of Longo's strategy of ...

Study: Functional decline in woman at risk for Alzheimer's relates to deteriorating brain

2015-03-30
TORONTO, March 30, 2015 - In their latest brain imaging study on women at risk for Alzheimer's disease, York University researchers have found deterioration in the pathways that serve to communicate signals between different brain regions needed for performing everyday activities such as driving a car or using a computer. "We observed a relationship between the levels of deterioration in the brain wiring and their performance on our task that required simultaneous thinking and moving; what we see here is a result of communication failure," explains Professor Lauren Sergio ...

LAST 30 PRESS RELEASES:

Study unexpectedly finds living in rural, rather than urban environments in first five years of life could be a risk factor for developing type 1 diabetes

Editorial urges deeper focus on heart-lung interactions in pulmonary vascular disease

Five University of Tennessee faculty receive Fulbright Awards

5 advances to protect water sources, availability

OU Scholar awarded Fulbright for Soviet cinema research

Brain might become target of new type 1 diabetes treatments

‘Shore Wars:’ New research aims to resolve coastal conflict between oysters and mangroves, aiding restoration efforts

Why do symptoms linger in some people after an infection? A conversation on post-acute infection syndromes

Study reveals hidden drivers of asthma flare-ups in children

Physicists decode mysterious membrane behavior

New insights about brain receptor may pave way for next-gen mental health drugs

Melanoma ‘sat-nav’ discovery could help curb metastasis

When immune commanders misfire: new insights into rheumatoid arthritis inflammation

SFU researchers develop a new tool that brings blender-like lighting control to any photograph

Pups in tow, Yellowstone-area wolves trek long distances to stay near prey

AI breakthrough unlocks 'new' materials to replace lithium-ion batteries

Making molecules make sense: A regional explanation method reveals structure–property relationships

Partisan hostility, not just policy, drives U.S. protests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: August 1, 2025

Young human blood serum factors show potential to rejuvenate skin through bone marrow

Large language models reshape the future of task planning

Narrower coverage of MS drugs tied to higher relapse risk

Researchers harness AI-powered protein design to enhance T-cell based immunotherapies

Smartphone engagement during school hours among US youths

Online reviews of health care facilities

MS may begin far earlier than previously thought

New AI tool learns to read medical images with far less data

Announcing XPRIZE Healthspan as Tier 5 Sponsor of ARDD 2025

Announcing Immortal Dragons as Tier 4 Sponsor of ARDD 2025

Reporting guideline for chatbot health advice studies

[Press-News.org] BMC study: New Hepatitis C treatments cost-effective, but only for selected patients